[The renin-angiotensin system in hypertension and in cardiovascular and renal diseases: highlights of the World Congress of Nephrology 2009]].
Santé active édition, 9 Villa Chanoine, 92270 Bois-Colombes, France.
M
M
Romet
D000803:Angiotensin I / Q000502:physiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000503:physiopathology* / Q000517:prevention & control; D004353:Drug Evaluation, Preclinical; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D007674:Kidney Diseases / Q000188:drug therapy / Q000503:physiopathology* / Q000517:prevention & control; D009398:Nephrology; D010446:Peptide Fragments / Q000502:physiology; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D051381:Rats; D044140:Receptor, Angiotensin, Type 1 / Q000187:drug effects / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology; D012083:Renin / Q000502:physiology; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology*; D000093342:Prorenin Receptor; D000092502:Renin Inhibitors
D000803:Angiotensin I; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D010446:Peptide Fragments; D044140:Receptor, Angiotensin, Type 1; D011956:Receptors, Cell Surface; D012083:Renin; D000093342:Prorenin Receptor; D000092502:Renin Inhibitors; C118790:angiotensin I (1-7)